Crossref
Immunotherapy plus stereotactic radiation therapy improves event‐free survival in early‐stage non–small cell lung cancer
Cancer · 2023
DOI: 10.1002/cncr.35088 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, 2023. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Radiosurgery, Small Cell Lung Carcinoma. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Carcinoma, Non-Small-Cell LungLung NeoplasmsRadiosurgerySmall Cell Lung CarcinomaHumansProgression-Free SurvivalImmunotherapyTreatment OutcomeNeoplasm Staging
Zitieren
APA
(2023). Immunotherapy plus stereotactic radiation therapy improves event‐free survival in early‐stage non–small cell lung cancer. Cancer. https://doi.org/10.1002/cncr.35088
Vancouver
Immunotherapy plus stereotactic radiation therapy improves event‐free survival in early‐stage non–small cell lung cancer. Cancer. 2023. doi:10.1002/cncr.35088
BibTeX
@article{euvimed2023,
title = {Immunotherapy plus stereotactic radiation therapy improves event‐free survival in early‐stage non–small cell lung cancer},
journal = {Cancer},
year = {2023},
doi = {10.1002/cncr.35088}
}
EUVIMED